Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Citigroup Reinstates Buy on Eli Lilly, Announces $1060 Price Target

Author: Benzinga Newsdesk | September 13, 2024 09:44am
Citigroup analyst Peter Verdult reinstates Eli Lilly (NYSE:LLY) with a Buy and announces $1060 price target.

Posted In: LLY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist